^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ZG19018

i
Other names: ZG19018
Twitter
Trials
Company:
Suzhou Zelgen
Drug class:
KRAS G12C inhibitor
Twitter
Trials